Marshall & Sterling Wealth Advisors Inc. Novartis Ag Transaction History
Marshall & Sterling Wealth Advisors Inc.
- $148 Billion
- Q2 2025
A detailed history of Marshall & Sterling Wealth Advisors Inc. transactions in Novartis Ag stock. As of the latest transaction made, Marshall & Sterling Wealth Advisors Inc. holds 505 shares of NVS stock, worth $63,130. This represents 0.04% of its overall portfolio holdings.
Number of Shares
505
Previous 490
3.06%
Holding current value
$63,130
Previous $54.6 Million
11.84%
% of portfolio
0.04%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding NVS
# of Institutions
1,593Shares Held
136MCall Options Held
1.72MPut Options Held
1.7M-
Dodge & Cox San Francisco, CA10.6MShares$1.33 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.3 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX9.06MShares$1.13 Billion0.26% of portfolio
-
Morgan Stanley New York, NY7.56MShares$945 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.12MShares$890 Million0.35% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $269B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...